SI3206694T1 - Uporaba neridronske kisline ali njene soli za zdravljenje osteoartroze - Google Patents

Uporaba neridronske kisline ali njene soli za zdravljenje osteoartroze

Info

Publication number: SI3206694T1
Authority: SI; Slovenia
Prior art keywords: osteoarthrosis; salt; treatment; neridronic acid; neridronic
Prior art date: 2014-10-15

Application number

SI201531345T

Other languages

English (en)

Inventor

Varenna Massimo

Original Assignee

Abiogen Pharma Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2014-10-15

Filing date

2015-10-15

Publication date

2020-11-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51904075&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI3206694(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2015-10-15 Application filed by Abiogen Pharma Spa filed Critical Abiogen Pharma Spa

2020-11-30 Publication of SI3206694T1 publication Critical patent/SI3206694T1/sl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Dermatology (AREA)
Physiology (AREA)
Nutrition Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Rheumatology (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Pain & Pain Management (AREA)
Physical Education & Sports Medicine (AREA)
Inorganic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Orthopedic Medicine & Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pyridine Compounds (AREA)

SI201531345T 2014-10-15 2015-10-15 Uporaba neridronske kisline ali njene soli za zdravljenje osteoartroze SI3206694T1 (sl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
ITMI20141794		2014-10-15
PCT/IB2015/057929 WO2016059594A1 (en)	2014-10-15	2015-10-15	Use of neridronic acid or of its salt for the treatment of osteoarthrosis
EP15797421.3A EP3206694B1 (en)	2014-10-15	2015-10-15	Use of neridronic acid or of its salt for the treatment of osteoarthrosis

Publications (1)

Publication Number	Publication Date
SI3206694T1 true SI3206694T1 (sl)	2020-11-30

Family

ID=51904075

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI201531345T SI3206694T1 (sl)	2014-10-15	2015-10-15	Uporaba neridronske kisline ali njene soli za zdravljenje osteoartroze

Country Status (32)

Country	Link
US (2)	US20170209470A1 (sl)
EP (1)	EP3206694B1 (sl)
JP (1)	JP6839076B2 (sl)
KR (1)	KR102591084B1 (sl)
CN (2)	CN111939164A (sl)
AU (1)	AU2015332060B2 (sl)
BR (1)	BR112017006989A2 (sl)
CA (1)	CA2963066C (sl)
CL (1)	CL2017000915A1 (sl)
CO (1)	CO2017003561A2 (sl)
CY (1)	CY1123420T1 (sl)
DK (1)	DK3206694T3 (sl)
DO (1)	DOP2017000096A (sl)
EA (1)	EA033191B1 (sl)
EC (1)	ECSP17023093A (sl)
ES (1)	ES2819186T3 (sl)
HR (1)	HRP20201475T1 (sl)
HU (1)	HUE052088T2 (sl)
IL (1)	IL251421B (sl)
LT (1)	LT3206694T (sl)
MX (1)	MX2017004826A (sl)
MY (1)	MY191481A (sl)
NZ (1)	NZ730853A (sl)
PE (1)	PE20170699A1 (sl)
PH (1)	PH12017500659A1 (sl)
PL (1)	PL3206694T3 (sl)
PT (1)	PT3206694T (sl)
RS (1)	RS60868B1 (sl)
SG (1)	SG11201702574XA (sl)
SI (1)	SI3206694T1 (sl)
TN (1)	TN2017000095A1 (sl)
WO (1)	WO2016059594A1 (sl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20190328755A1 (en) *	2018-04-30	2019-10-31	Grunenthal Gmbh	Methods of treating complex regional pain syndrome (crps) or symptoms comprising administration of neridronic acid

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2784031B1 (fr) *	1998-10-02	2002-02-01	Sanofi Elf	Utilisation de derives de l'acide bisphosphonique pour la preparation d'un medicament destine au traitement des boiteries
JP2005516928A (ja) *	2001-12-13	2005-06-09	メルク　エンド　カムパニー　インコーポレーテッド	骨異常のためのビスホスホネート液体製剤
ITMI20040218A1 (it) *	2004-02-10	2004-05-10	Abiogen Pharma Spa	Uso di neridronato sodico per promuovere la neoformazione ossea
AU2005240107A1 (en) *	2004-05-06	2005-11-17	Merck & Co., Inc.	Methods for treating arthritic conditions in dogs
AU2007212508A1 (en) *	2006-02-06	2007-08-16	Cypress Bioscience, Inc.	Compositions comprising a bisphosphonate and an antifolate
US20070191315A1 (en) *	2006-02-16	2007-08-16	Bengt Bergstrom	Method for administering ibandronate
CA2987470A1 (en) *	2012-05-14	2013-11-21	Antecip Bioventures Ii Llc	Compositions comprising zoledronic acid or related compounds for relieving inflammatory pain and related conditions

2015
- 2015-10-15 MY MYPI2017701067A patent/MY191481A/en unknown
- 2015-10-15 HU HUE15797421A patent/HUE052088T2/hu unknown
- 2015-10-15 SG SG11201702574XA patent/SG11201702574XA/en unknown
- 2015-10-15 HR HRP20201475TT patent/HRP20201475T1/hr unknown
- 2015-10-15 SI SI201531345T patent/SI3206694T1/sl unknown
- 2015-10-15 WO PCT/IB2015/057929 patent/WO2016059594A1/en not_active Ceased
- 2015-10-15 EP EP15797421.3A patent/EP3206694B1/en active Active
- 2015-10-15 PT PT157974213T patent/PT3206694T/pt unknown
- 2015-10-15 KR KR1020177010305A patent/KR102591084B1/ko active Active
- 2015-10-15 US US15/514,651 patent/US20170209470A1/en not_active Abandoned
- 2015-10-15 ES ES15797421T patent/ES2819186T3/es active Active
- 2015-10-15 DK DK15797421.3T patent/DK3206694T3/da active
- 2015-10-15 CN CN202010813830.1A patent/CN111939164A/zh active Pending
- 2015-10-15 TN TN2017000095A patent/TN2017000095A1/en unknown
- 2015-10-15 CA CA2963066A patent/CA2963066C/en active Active
- 2015-10-15 CN CN201580055571.8A patent/CN106794190A/zh active Pending
- 2015-10-15 PE PE2017000541A patent/PE20170699A1/es unknown
- 2015-10-15 MX MX2017004826A patent/MX2017004826A/es unknown
- 2015-10-15 AU AU2015332060A patent/AU2015332060B2/en active Active
- 2015-10-15 JP JP2017519665A patent/JP6839076B2/ja active Active
- 2015-10-15 RS RS20201089A patent/RS60868B1/sr unknown
- 2015-10-15 EA EA201790531A patent/EA033191B1/ru not_active IP Right Cessation
- 2015-10-15 LT LTEP15797421.3T patent/LT3206694T/lt unknown
- 2015-10-15 PL PL15797421T patent/PL3206694T3/pl unknown
- 2015-10-15 BR BR112017006989-0A patent/BR112017006989A2/pt not_active Application Discontinuation
- 2015-10-15 NZ NZ730853A patent/NZ730853A/en unknown
2017
- 2017-03-27 IL IL251421A patent/IL251421B/en unknown
- 2017-04-07 PH PH12017500659A patent/PH12017500659A1/en unknown
- 2017-04-10 DO DO2017000096A patent/DOP2017000096A/es unknown
- 2017-04-12 CL CL2017000915A patent/CL2017000915A1/es unknown
- 2017-04-12 CO CONC2017/0003561A patent/CO2017003561A2/es unknown
- 2017-04-13 EC ECIEPI201723093A patent/ECSP17023093A/es unknown
2020
- 2020-09-15 CY CY20201100872T patent/CY1123420T1/el unknown
2023
- 2023-03-29 US US18/192,094 patent/US20230233585A1/en active Pending

Also Published As

Publication number	Publication date
CN106794190A (zh)	2017-05-31
EP3206694B1 (en)	2020-07-08
AU2015332060A1 (en)	2017-04-27
DOP2017000096A (es)	2017-07-31
NZ730853A (en)	2018-06-29
MY191481A (en)	2022-06-28
MX2017004826A (es)	2018-01-24
CA2963066C (en)	2023-12-05
PH12017500659A1 (en)	2017-10-02
EA201790531A1 (ru)	2017-08-31
HRP20201475T1 (hr)	2020-12-11
ECSP17023093A (es)	2017-06-30
AU2015332060B2 (en)	2018-06-07
SG11201702574XA (en)	2017-04-27
US20230233585A1 (en)	2023-07-27
HUE052088T2 (hu)	2021-04-28
EA033191B1 (ru)	2019-09-30
JP6839076B2 (ja)	2021-03-03
CA2963066A1 (en)	2016-04-21
CO2017003561A2 (es)	2017-09-11
LT3206694T (lt)	2020-11-25
ES2819186T3 (es)	2021-04-15
WO2016059594A1 (en)	2016-04-21
IL251421B (en)	2022-05-01
IL251421A0 (en)	2017-05-29
RS60868B1 (sr)	2020-11-30
PL3206694T3 (pl)	2020-12-28
EP3206694A1 (en)	2017-08-23
PE20170699A1 (es)	2017-06-03
BR112017006989A2 (pt)	2018-03-27
CL2017000915A1 (es)	2017-11-10
US20170209470A1 (en)	2017-07-27
CN111939164A (zh)	2020-11-17
JP2017532333A (ja)	2017-11-02
PT3206694T (pt)	2020-09-22
KR102591084B1 (ko)	2023-10-18
CY1123420T1 (el)	2021-12-31
KR20170066438A (ko)	2017-06-14
DK3206694T3 (da)	2020-09-21
TN2017000095A1 (en)	2018-07-04

Publication	Publication Date	Title
HUS2100037I1 (hu)	2021-10-28	Vegyületek gerinc eredetû izomsorvadás kezelésére
IL253945A0 (en)	2017-10-31	kdm1a inhibitors to treat the disease
IL252873A0 (en)	2017-08-31	The l-tartrate salt of pridopidine
IL247515A0 (en)	2016-11-30	Snekribirock for the treatment of leprosy
IL250960B (en)	2021-07-29	Combined treatment of sinecriviroc for the treatment of leprosy
EP3180009A4 (en)	2018-03-14	Zoledronic acid dosage forms for the treatment of pain
ZA201608843B (en)	2019-04-24	Chloride salt of tat-nr2b9c
IL249502A0 (en)	2017-02-28	Novel therapeutic uses of benzylideneguanidine derivatives for the treatment of protein-associated diseases
SG11201604954YA (en)	2016-07-28	Novel tetrahydropyridopyrimidine compound or salt thereof
SG11201702700UA (en)	2017-04-27	Methods for the treatment of peri-implantitis
HUE070257T2 (hu)	2025-05-28	Vegyületek a lipofuscinhoz kapcsolódó betegségek kezelésére
EP3145525A4 (en)	2018-03-07	Use of microperoxidases for the treatment of carboxyhemoglobinemia
IL259073A (en)	2018-06-28	History of abscisic acid - converted at the 3' position
PT3340975T (pt)	2019-11-04	Formulação para o tratamento de acne
IL251421B (en)	2022-05-01	Use of neridronic acid or its salt to treat arthritis
GB201412010D0 (en)	2014-08-20	Treatment of hypertransaminasemia